Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
Public ClinicalTrials.gov record NCT02895100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Randomised, Double-blind, Placebo-controlled, Parallel, Adaptive 2-Stage, Multi-Centre Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects With Moderate to Severe Active Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main objectives of this study are to evaluate the efficacy, safety, and tolerability of daily doses of PTG-100 in subjects with moderate to severe ulcerative colitis (UC).
Study identification
- NCT ID
- NCT02895100
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 98 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2016 (Type not available)
- Primary completion
- Mar 26, 2018 (Actual)
- Completion
- Mar 26, 2018 (Actual)
- Last update posted
- Aug 21, 2025
2016 – 2018
United States locations
- U.S. sites
- 21
- U.S. states
- 12
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator # 101 | Los Angeles | California | 90036 | — |
| Site Reference ID/Investigator # 102 | Los Angeles | California | 90036 | — |
| Site Reference ID/Investigator # 125 | Colorado Springs | Colorado | 80907 | — |
| Site Reference ID/Investigator # 120 | Miami | Florida | 33126 | — |
| Site Reference ID/Investigator # 106 | Port Orange | Florida | 32128 | — |
| Site Reference ID/Investigator # 115 | Saint Augustine | Florida | 32086 | — |
| Site Reference ID/Investigator # 116 | Sweetwater | Florida | 33172 | — |
| Site Reference ID/Investigator # 100 | Atlanta | Georgia | 30607 | — |
| Site Reference ID/Investigator # 104 | Marietta | Georgia | 30060 | — |
| Site Reference ID/Investigator # 112 | Suwanee | Georgia | 30024 | — |
| Site Reference ID/Investigator # 107 | Chicago | Illinois | 60611 | — |
| Site Reference ID/Investigator # 126 | Bastrop | Louisiana | 71220 | — |
| Site Reference ID/Investigator # 114 | Shreveport | Louisiana | 71105 | — |
| Site Reference ID/Investigator # 117 | Chevy Chase | Maryland | 20815 | — |
| Site Reference ID/Investigator # 109 | Great Neck | New York | 11021 | — |
| Site Reference ID/Investigator # 122 | New York | New York | 10065 | — |
| Site Reference ID/Investigator # 119 | Cincinnati | Ohio | 45219 | — |
| Site Reference ID/Investigator # 110 | Hermitage | Tennessee | 37076 | — |
| Site Reference ID/Investigator # 128 | Nashville | Tennessee | 37212 | — |
| Site Reference ID/Investigator # 118 | DeSoto | Texas | 75035 | — |
| Site Reference ID/Investigator # 113 | Richmond | Virginia | 23249 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 77 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02895100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 21, 2025 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02895100 live on ClinicalTrials.gov.